Low-Level Delamanid and Bedaquiline Resistance in Extensively Drug-Resistant TB - Infectious Disease Advisor https://t.co/JJ6E7TEjDB — IDRO (@IDROOhio) April 30, 2019
Low-Level Delamanid and Bedaquiline Resistance in Extensively Drug-Resistant TB - Infectious Disease Advisor https://t.co/JJ6E7TEjDB
No comments:
Post a Comment